1.
The paper needs a solid edit from a native English speaker for language, grammar, spelling, and usage.
2.
Details of the human population need to be provided, including exclusion criteria, status about the women's menstrual cycles (or use of steroid contraceptives), time of day of collection, and other experimental details.
3.
Were field blanks used for the measures of BHPF in human serum? This is essential and appears to have been omitted.
4.
In the yeast assay, the range of dosages used for BHPF should be extended into the lower range. EDCs are well-established as acting with non-monotonic dose-response curves and sometimes low dose effects are seen in the absence of high dose effects.
5.
In vivo work on mice evaluates crude gross morphological changes that are crude that endocrinologists agree are poor measures of either estrogenic or anti-estrogenic activity. Neither the established uterotrophic assay is, or the author's new anti-uterotrophic assay, is a cutting-edge assay of hormonal actions. Similarly, global gene expression profiling of whole organs is not usually terribly informative, as tissues are highly heterogeneous.
6.
By "intragastric administration" do the authors mean oral gavage, or were they surgically implanted with a feeding tube? This requires clarification. Moreover, gavage is highly stressful and should be avoided.
7.
Justification and clarification of the dose of BHPF needs to be provided. In the antiuterotrophic assay, the authors say administration was 5 mL/kg BW which is not meaningful. For the qPCR work, authors mention 50 mg/kg BW. If this was the dose given in prior studies, it is an unrealistic dose and not relevant to human exposures. Subsequent work on subchronic toxicity uses a range of dosing from 0.4 to 50 mg/kg, still in a high range.
8.
The authors might consider doing the obvious experiment of allowing the mice to drink from water bottles with BHPF, compared to a vehicle water bottle. This would avoid the gavage problem and would use realistic amounts.
9.
Mating studies were conducted with same-treatment males and females. It is important to mate treated animals with non-treated controls.
10.
In Figure 4 legend, clarify that heatmaps are shown relative to the control group.
11. The discussion of NOAEL needs to include work on much lower dosages, showing adverse effects well below the predicted NOAEL.
12. There are other mechanisms of action of bisphenols beyond estrogen signaling that should be discussed.
Reviewer #3 (Remarks to the Author):
General Comments:
First, I note that the Editor asked me to pay specific attention to the analytical-chemistry and the statistical aspects of this work. These are certainly most central to my expertise; however, I am also reasonable well qualified to judge the (anti-)estrogenic assays and microarray results. The histopathology and some details of the in vivo studies are the only aspects of the paper that are beyond my comfortable reach. This is a very thorough, compelling, and interesting piece of work. The Authors conducted experiments that span a wide range of disciplines, assembling all the pieces needed to strongly "make their case". Specifically, they show conclusively that: 1) fluorene-9-bisphenol (BHPF) occurs in plastic bottles (using 1H-NMR and 13C-NMR), 2) BHPF leaches from bottles into drinking water (using GC-MS with an in-house synthesized deuterated form of BHPF as an internal standard), 3) BHPF is detected (albeit at low occurrence rate) in serum in the general public (using 100 volunteers), and 4) BHPF is a potent anti-estrogen. To establish the anti-estrogenic mode of action, the Authors use multiple lines of persuasive evidence demonstrating that BHPF: a) blocks the activity of estradiol (on par with a model anti-estrogen) in a well-established yeast assay for estrogenicity, b) fits nicely within the antagonist pocket (but not the agonist pocket) of the estrogen receptor using in silico molecular docking software, c) inhibits relative uterine weight (in a dose-dependent manner) in an optimized in vivo screen for anti-estrogenicity (in similar fashion with a model anti-estrogen), d) selectively down-regulates (in a dose-dependent manner) virtually all of the transcripts that are upregulated by estradiol in mouse microarrays, e) reduces relatively uterine weight in reproductive toxicology in vivo studies (as do model anti-estrogens), and f) impacts tissues similar to model antiestrogens as viewed by histology.
All of these lines of evidence are laid out in a very logical fashion. The Authors use these results to illustrate the larger implications that: a) alternatives to BPA may be as harmful, or more harmful, to the public as BPA, b) thus, the various pressures (regulations, public concerns, etc.) that force companies to replace "hot button" chemicals may be doing more harm than good, c) the topic of anti-estrogens in the environment -much less studied than that of estrogens -deserves more attention from researchers. I have heard each of these larger points a few times before, although each is "fresh" enough that I would consider them relatively novel. Indeed, I cannot recall a single case where these points were made in a more-compelling and thorough manner. I feel strongly that this paper would be of interest to those in the Environmental Science community. On a personal note, I am involved in work that uses chemical monitoring data from waste water treatment plants. Of course, I will abide by the Journal's rules of confidentiality, but I am very curious to know if BHPF could be measured in any of these samples. I do feel that this paper, once published, will likewise impact the thinking of others in this field.
My recommendation is to accept this paper will minor modifications. I have read the scope and criteria for publication for Nature Communications, and I think this paper is well suited. Following are some specific comments that are aimed at improving the presentation (and also some comments regarding the Editor's specific charge to assess the statistical and analytical methodology). 1) With regard to statistics -there really is nothing "fancy" here -which is as it should be. The Authors use 10 replicates, which is about as good as you see with in vivo rodent studies. A wellestablished statistical program is used; differences in classes are assessed with ANOVA using Fisher's as a post-hoc test. In the figures, error bars are generated using standard deviation, which, to their credit, is more conservative than standard-error-of-the-mean error bars (which is often used). If I wanted to be nitpicky, I would point out that Fisher's test is a little less conservative than Tukey's test, but that is really more of a personal preference, and would probably not make any difference. Also, the Authors do not state whether or not they tested the data for normality and heteroscedasticity before applying the ANOVA tests. Strictly speaking, ANOVA is only applicable for data that meet these criteria (although a small degree of non-adherence is well tolerated). Looking at the data, I suspect there are no problems, but it might be worthwhile to close that loop.
2) With regard to analytical measurements -The Author's choices for analyses seem perfectly appropriate. They initially used 1H-NMR and 13C-NMR to confirm that BHPF was leaching from a plastic bottle. BHPF was isolated by fractionating a methanol leachate. NMR is the "gold standard" for identifying (or confirming the identity) of a relatively pure organic chemical. Using both 1H and 13C NMR takes this analysis to a very high level of confidence. My only quibble with this part of the work is that I would have liked to see a Figure with a more explicit comparison of the NMR spectrum of the isolate with that of an authentic standard of BHPF. I feel sure that the Authors have made this comparison for their own sake -indeed, I think the NMR spectrum in Supplementary Information Figure 1A is for the authentic standard. However, this is not clearly stated, and it is not presented in a way that can be compared directly to the NMR spectrum of the isolate in Figure 1 .
Once identified, the Authors used GC/MS (with derivatization) to quantify BHPF in drinking water and in human serum. They included a partially deuterated form of BHPF (which was synthesized inhouse) as an internal standard. Again, this is the "gold standard" method for target analysis (and quantification) of an organic chemical whose mass spectrum and GC retention time is known. No qualms here.
3) It seems that there has been some inversions (typos) when referring to Figures and sub-parts of Figures. For example, in the Caption, Figure 7D is described as "dead fetus ...". It seems pretty clear that Figure 7C is actually the dead fetus (and it is referred to as such in the text). In addition, the "order" of Figure 5 and Figure 6 (the actual graphics) are switched (6 appears in the document before 5). And, it appears that some text references to 5/6 are reversed. I am not sure I caught all of these issues, so beware! 4) The microarray results regarding the opposing effects of BHPF and E2 (described from lines 154 -170, and depicted in Figure 4 ) are very compelling and useful to the argument. However, the more "global" microarray-results discussion in lines 127 -154 is not very useful. While there are a few good points in that section, in my view, the vast majority of the text from line 127 -154 could be omitted or perhaps moved to Supplementary Information. 5) I thought the paper would be more impactful if the Discussion had ended with line 283, which is an effective climactic sentence. The paragraph that follows (line 284-293) is mostly a repetitive summary of the technical findings. I suggest moving any useful thoughts from lines 284-293 to earlier in the Discussion, and closing with the preceding paragraph that ends on line 283.
6) The English linguistics of this paper is quite good; however, some issues will need to be addressed. For example, "drinking water" is called "drink water". I will not list more here, but several other subtle misusages appear.
Finally, I would note that the references seemed appropriate, and that all sections of the manuscript were clear, lucid, and very well written and organized.
Reviewer #4 (Remarks to the Author):
Molecular docking of BHPF Molecular docking was performed using the commercial software Scigress (Ultra Version 3.0.0, Fujitsu. It shows that BHPF can be accommodated into the antagonist pocket of ERα (PDB ID 3ERT), and not in the agonist pocket (PDB ID 1ERE) (Fig. 2c-e) . The position of BHPF in the pocket is rather similar to that of OHT observed in the crystal structure. The approach used is a standard one. Considering the stereochemistry of the two ligands the results are convincing and not surprising. (which is considerable already) to use a full length human receptor and evaluate separate effects on ERa and ERb. Recognizing that this may be deemed to be outside the scope of this original paper. The description of the data in humans should be perhaps more completely described. First, this should not be described as "general population", but rather volunteers. How were these volunteers identified and selected? What age, sex, etc. Other characteristics? This self-selection process could produce a bias. Second, are the authors confidence that the measurements of BHPF in human serum is not the result of contamination from plastics employed in the procedure? If no field blanks or tests of equipment was performed, the authors ne ed to be very careful about these conclusions. Moreover, there were very few volunteers that exhibited BHPF levels and this should be reflected in the abstract and summaries ("...was detected in a small proportion of volunteers"...). The animal studies appear appropriate. However, it might be useful to describe the methods employed to reduce the risk of bias in data collection. Method of animal assignment, sequence of gavage and animal collection, time of day, etc.
A separate subsection in the supplementary material might be useful for this.
Response: Thank you very much for your very helpful and constructive comments. To specifically answer these comments, we have divided the "Comment C" into 3 parts and responded the comments point by point, as follows:
Comment C-1. Data and methodology. This reviewer cannot evaluate the quality of the chemistry approaches. However, there are potential concerns for consideration. First, the YES assay has certain weaknesses associated with the mosaic nature of the target receptor. It would strengthen the body of work (which is considerable already) to use a full length human receptor and evaluate separate effects on ERa and ERb. Recognizing that this may be deemed to be outside the scope of this original paper.
Response: According to your suggestion, we performed dual-luciferase reporter assays which comprised a full-length human estrogen receptor α or β, and the anti-estrogenicity of BHPF have been demonstrated by the DLR assays. The following sentences and Fig. 2c-2f were added in the revised manuscript.
"The dual-luciferase reporter assay comprised a full-length human estrogen receptor α or β and estrogen response elements (EREs)." (page 5, lines 92-93)
"Similarly, BHPF showed no estrogenic activity but strong anti-estrogenic activities in the dual-luciferase reporter assays 
.).
Response: According to your suggestion, we replaced the "general population" with "volunteers", added "be detectable in the serum of a small proportion of human volunteers" in the abstract and summaries, and added more clinical information and experimental details on the human volunteers and serum sample measurements in the revised manuscript. The following sentences were added in the revised manuscript: Response: Thank you for your comment. In the yeast assay, we had studied lower concentrations of BHPF in preliminary experiments, and no obvious effect was found.
In the dual-luciferase reporter assays, we studied lower concentrations of BHPF and found BHPF took anti-estrogenic effect at lower concentrations. According to your suggestions, we added the results of dual-luciferase reporter assays in Fig. 2 in the revised manuscript, and the following sentences were added in the revised manuscript.
"Similarly, BHPF showed no estrogenic activity but strong anti-estrogenic activities in the dual-luciferase reporter assays (Fig. 2c-2f) Response: According to your suggestions, we changed the "intragastric administration"
to "oral gavage", and an exposure experiment through drinking water using mice was performed to avoid stress caused by gavage in the revised manuscript. We agree with you that gavage may induce stress. But oral gavage is still widely employed in animal experiments and accepted by standard evaluation procedures of OECD (OECD Test
No. 440), US EPA (OCSPP Guideline 890.1600), etc. In addition, it should be pointed out that: 1) the operators for oral gavage are highly skilled in this study and highly skilled operators would greatly reduce the stress on mice; 2) the mice were pregavaged with vehicle before dosing for acclimatization; 3) the mice of control group were treated by gavage in the same way as those of test groups. These measures helped to prevent influences of gavage on experiment. 2) The "5 mL/kg BW" was the volume of vehicle or chemical solutions administered. According to your comment, the original sentence with "5 mL/kg BW" was revised to make it legible.
3) The experiment with 50 mg/kg BW group, as well as a control, was specifically conducted for the expression profiling and Q-RT-PCR works. According to your comment, we added more details about the experiment. 4)
According to the suggestion of "experiment of allowing the mice to drink from water bottles with BHPF", we performed exposure experiment through drinking water using mice, and studied the effects of low doses of BHPF relevant to human exposure. The following sentences were added or revised in the revised manuscript:
" (Fig. 8a) . The gene expressions of sprr2a and sprr2b in the uteri of the mice were also studied by Q-RT-PCR (Fig. 8b) Response: Thank you for your comment. In this study, in cases where pairing was unsuccessful, females were re-mated with proven males of the same group, except that females in the 1.2 mg/kg TAM group were re-mated with proven males of the control group because all of the females were non-pregnant in the TAM-treated group.
This procedure is in reference to the mating procedures of reproduction toxicity Tests of OECD Guideline for Testing of Chemicals (OECD Test No. 416, 421, and 422) . , estrogen-related receptor gamma, pregnane X receptor, etc 2,16,20-22 . The microarray analysis also showed that some genes involved in biotransformation and estrogen metabolism were up-regulated in the uteri of the BHPF-treated mice (Fig. 4b) All of these lines of evidence are laid out in a very logical fashion. The Authors use these results to illustrate the larger implications that: a) alternatives to BPA may be as harmful, or more harmful, to the public as BPA, b) thus, the various pressures (regulations, public concerns, etc.) that force companies to replace "hot button" chemicals may be doing more harm than good, c) the topic of anti-estrogens in the environment -much less studied than that of estrogensdeserves more attention from researchers. I have heard each of these larger points a few times before, although each is "fresh" enough that I would consider them relatively novel. Indeed, I cannot recall a single case where these points were made in a more-compelling and thorough manner. I feel strongly that this paper would be of interest to those in the Environmental Science community. On a personal note, I am involved in work that uses chemical monitoring data from waste water treatment plants. Of course, I will abide by the Journal's rules of confidentiality, but I am very curious to know if BHPF could be measured in any of these samples. I do feel that this paper, once published, will likewise impact the thinking of others in this field.
My recommendation is to accept this paper will minor modificati ons. I have read the scope and criteria for publication for Nature Communications, and I think this paper is well suited. Following are some specific comments that are aimed at improving the presentation (and also some comments regarding the Editor's specific charge to assess the statistical and analytical methodology). 13C-NMR to confirm that BHPF was leaching from a plastic bottle. BHPF was isolated by fractionating a methanol leachate. NMR is the "gold standard" for identifying (or confirming the identity) of a relatively pure organic chemical. Figure 1A is for the authentic standard.
However, this is not clearly stated, and it is not presented in a way that can be compared directly to the NMR spectrum of the isolate in Figure 1 . Once identified, the Authors used GC/MS (with derivatization) to quantify BHPF in drinking water and in human serum. They included a partially deuterated form of BHPF (which was synthesized in-house) as an internal standard. Again, this is the "gold standard" method for target analysis (and quantification) of an organic chemical whose mass spectrum and GC retention time is known. No qualms here.
Response: Thank you for your comments and suggestions. Because the NMR spectrum was reported previously by Liu et al. (2008) , the NMR spectrum of BHPF standard was not shown in this manuscript, but we added the following sentence in the revised manuscript to make it legible according to your suggestion. Figure 7D is described as "dead fetus ...". It seems pretty clear that Figure 7C is actually the dead fetus (and it is referred to as such in the text). In addition, the "order" of Figure 5 and Figure 6 (the actual graphics) are switched (6 appears in the document before 5). And, it appears that some text references to 5/6 are reversed. I am not sure I caught all of these issues, so beware! Response: Thank you for your careful works on review this manuscript. According to your suggestions, we conducted a careful modification of the manuscript, and the errors were corrected. Comment 6. The English linguistics of this paper is quite good; however, some issues will need to be addressed. For example, "drinking water" is called "drink water". I will not list more here, but several other subtle misusages appear.
Finally, I would note that the references seemed appropri ate, and that all sections of the manuscript were clear, lucid, and very well written and organized.
Response: According to your suggestion, we conducted a careful modification of the manuscript and corrected the errors, and two native English language editors had help us to revise the manuscript.
